|
CHCHD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.477900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.856200E-03 |
| Normal-vs-Stage2 |
3.114200E-01 |
| Normal-vs-Stage3 |
5.718500E-02 |
| Normal-vs-Stage4 |
4.706200E-02 |
| Stage1-vs-Stage2 |
2.562100E-02 |
| Stage1-vs-Stage3 |
7.900800E-01 |
| Stage1-vs-Stage4 |
8.860000E-01 |
| Stage2-vs-Stage3 |
4.556000E-02 |
| Stage2-vs-Stage4 |
3.443600E-02 |
| Stage3-vs-Stage4 |
7.542000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.036000E-03 |
| Normal-vs-AfricanAmerican |
6.670800E-01 |
| Normal-vs-Asian |
4.030600E-01 |
| Caucasian-vs-AfricanAmerican |
1.055650E-01 |
| Caucasian-vs-Asian |
3.395000E-01 |
| AfricanAmerican-vs-Asian |
6.752000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.135400E-03 |
| Normal-vs-Female |
1.122770E-01 |
| Male-vs-Female |
5.262300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.624200E-02 |
| Normal-vs-Age(41-60Yrs) |
5.700400E-02 |
| Normal-vs-Age(61-80Yrs) |
3.399000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.084600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.107600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.494600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.899000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.266600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.641000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.187030E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.743800E-01 |
| Classical-VS-Follicular |
6.417800E-02 |
| Classical-VS-Other |
2.490800E-01 |
| Classical-VS-Normal |
8.117000E-03 |
| Tall-VS-Follicular |
6.235200E-01 |
| Tall-VS-Other |
8.101800E-02 |
| Tall-VS-Normal |
6.060400E-01 |
| Follicular-VS-Other |
1.776610E-01 |
| Follicular-VS-Normal |
9.061000E-01 |
| Other-VS-Normal |
9.801000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.713600E-02 |
| Normal-vs-N1 |
1.733600E-02 |
| N0-vs-N1 |
2.514600E-01 |
|
|
